Integra LifeSciences Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Integra LifeSciences (IART) Reports In-Line Q2 EPS; Tightens FY Rev Range
July 26, 2017 6:05 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.45, in-line with the analyst estimate of $0.45. Revenue for the quarter came in at $282.2 million versus the consensus estimate of $283.7 million.
The company is tightening full-year 2017 revenue guidance to a new range of $1.125 billion to $1.140 billion,... More